References

Braak H, Braak E. Neuropathological staging of Alzheimer - related changes.
Acta Neuropathol 1991;82;239-59.

Curtis C. et al. Phase 3 Trial of Flutemetamol Labeled With Radioactive Fluorine
18 Imaging and Neuritic Plaque Density. JAMA Neurol. 2015 Mar;72(3):287-94.

Hyman BT, Phelps CH, Beach TG et al.National Institute on Aging-Alzheimer's
Association guidelines for the neuropathologic assessment of Alzheimer's
disease. Alzheimers Dement 2012; 8 ; 1-13.

Mckhann G, Drachman D, Folstein M et al. Clinical diagnosis of Alzheimer's
disease: report of the NINCDS-ADRDA Work Group under the auspices of
Department of Health and Human Services Task Force on Alzheimer's Disease.
Neurology 1984; 34; 939-44.

Mckhann G, Knopman D, Chertkow H et al. The diagnosis of dementia due to
Alzheimer's disease: Recommendations from the National Institute on Aging-
Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's
disease. Alzheimers Dement 2011; 7: 263-9.

Mirra SS, Heyman A, McKeel D et al. The Consortium to Establish a Registry for
Alzheimer's Disease{CERAD}.Part II. Standardization of the neuropathologic
assessment of Alzheimer's disease. Neurology 1991; 41: 479-86.

Rowe CC, Ng S, Ackermann U, Gong SJ, Pike K, Savage G et al. Imaging
b-amyloid burden in aging and dementia. Neurology 2007, 68: 1718-25.